Fig. 5From: Noninvasive serum N-glycans associated with ovarian cancer diagnosis and precancerous lesion predictionDiscriminative models illustrating the power of serum N-glycome for precancerous lesion prediction. A Linear discriminant analysis (LDA) of serum N-glycans for distinguishing cancer patients from benign neoplasms; B ROC analysis of serum N-glycome, HE4 and CA125 between benign patients and OC patients with early stageBack to article page